Thorne Enters into Definitive Agreement to Be Acquired by Procter & Gamble

Thorne, a leader in science-backed health and wellness solutions, has entered into a definitive agreement to be acquired by The Procter & Gamble Company (NYSE: PG) for an undisclosed amount. The announcement was made on August 4, 2026, and the transaction is expected to close later this year, pending customary closing conditions and regulatory approvals. This acquisition positions Thorne to further its mission of becoming the world's most trusted personalized health brand while maintaining its commitment to quality and innovation.

Founded in 1984, Thorne has established itself as a trusted partner to healthcare practitioners and consumers by providing high-quality nutritional supplements and innovative technology tools. The company’s rigorous approach to science and manufacturing has garnered the trust of healthcare professionals, athletes, and millions of consumers. Thorne's vertically integrated model, which includes its own manufacturing facility in South Carolina, sets a high standard in the supplement industry, ensuring that its products meet stringent criteria for purity, potency, and efficacy.

The strategic rationale behind the acquisition lies in P&G's objective to strengthen its position in the growing premium wellness market. As consumer interest in self-care and personalized health continues to rise, the addition of Thorne’s trusted brand complements P&G's existing portfolio of health and wellness products. Paul Gama, CEO of P&G Health Care, emphasized that Thorne's science-backed offerings align with P&G’s commitment to quality and innovation, enhancing its capabilities in the health sector.

This acquisition reflects broader trends within the health and wellness industry, where there is an increasing demand for personalized and science-based health solutions. As consumers become more health-conscious, companies that can provide credible, research-backed products are likely to see sustained growth. The integration of Thorne into P&G's expansive global operations could lead to enhanced distribution and marketing capabilities, allowing Thorne to reach a wider audience while remaining true to its core values.

In conclusion, the acquisition of Thorne by Procter & Gamble underscores the growing importance of science-backed wellness solutions in the consumer market. As P&G aims to solidify its leadership in the premium wellness sector, this transaction may set the stage for further consolidation within the industry, as companies seek to capitalize on the increasing consumer focus on health and well-being. The successful integration of Thorne could serve as a model for future acquisitions, emphasizing the significance of maintaining brand integrity while expanding market reach.